LIQUID-CHROMATOGRAPHIC ASSAY OF SILYBIN IN HUMAN PLASMA AND URINE

被引:30
作者
MARTINELLI, EM
MORAZZONI, P
LIVIO, S
UBERTI, E
机构
[1] Invemi della Beffa S.pA., Research and Development Laboratories, 20141, Milan
来源
JOURNAL OF LIQUID CHROMATOGRAPHY | 1991年 / 14卷 / 07期
关键词
D O I
10.1080/01483919108049321
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A specific and sensitive high-performance liquid chromatographic method for the quantitative determination of silybin and its conjugates in human plasma and urine was developed. Silybin glucuronides and sulfates were calculated as silybin after enzymatic hydrolysis with beta-glucuronidase/arylsulfatase. Extraction from the biological fluid was performed at pH 4 on normal-phase solid extraction columns using tert-butylmethylether as eluent. (+)-Catechin was added as internal standard after the extraction procedure. A normal-phase column was used for the HPLC analysis. The mobile phase consisted of n-hexane/ethanol, acidified with 85% phosphoric acid. Detection was performed by a variable-wavelength detector at 214 nm. Detection limits of 5 and 25 ng/ml were respectively achieved for free and total (free and conjugated) silybin in plasma, and 100 ng/ml in urine. The method is suitable for pharmacokinetic studies after oral administration of IdB 1016, a lipophilic silybin-phosphatidylcholine complex.
引用
收藏
页码:1285 / 1296
页数:12
相关论文
共 12 条
[1]  
CHASSEAUD LF, 1975, DTSCH APOTH ZTG, V115, P1205
[2]   STUDIES ON THE ANTIOXIDANT AND FREE-RADICAL SCAVENGING PROPERTIES OF IDB-1016 A NEW FLAVANOLIGNAN COMPLEX [J].
COMOGLIO, A ;
LEONARDUZZI, G ;
CARINI, R ;
BUSOLIN, D ;
BASAGA, H ;
ALBANO, E ;
TOMASI, A ;
POLI, G ;
MORAZZONI, P ;
MAGISTRETTI, MJ .
FREE RADICAL RESEARCH COMMUNICATIONS, 1990, 11 (1-3) :109-115
[3]   STUDIES ON ELIMINATION OF SILYMARIN IN CHOLECYSTECTOMIZED PATIENTS .1. BILIARY AND RENAL ELIMINATION AFTER A SINGLE ORAL DOSE [J].
FLORY, PJ ;
KRUG, G ;
LORENZ, D ;
MENNICKE, WH .
PLANTA MEDICA, 1980, 38 (03) :227-237
[4]  
GABETTA B, 1989, 37TH ANN C MED PLANT
[5]  
GABETTA B, Patent No. 209030
[6]  
GABETTA B, Patent No. 4764508
[7]  
GRIFFITHS LA, 1982, STUD ORG CHEM, V11, P451
[8]  
LANG W, 1979, 3 EXP KLIN HEP INT L
[9]  
LORENZ D, 1984, Methods and Findings in Experimental and Clinical Pharmacology, V6, P655
[10]   STUDIES ON THE ELIMINATION OF SILYMARIN IN CHOLECYSTECTOMIZED PATIENTS .2. BILIARY ELIMINATION FOLLOWING A MULTIPLE ORAL DOSAGE [J].
LORENZ, D ;
MENNICKE, WH ;
BEHRENDT, W .
PLANTA MEDICA, 1982, 45 (04) :216-223